[Answered] Critically analyse how India’s RDI Fund accelerates deep-tech innovation while addressing governance and conflict-of-interest challenges in public fund allocation.

Introduction

India’s RDI Fund marks a strategic shift from public-only research towards state-enabled private innovation. With ₹1 lakh crore over six years, it targets India’s low business R&D intensity and financing gap.

Accelerating Deep-Tech Innovation

1. Patient capital: Primarily unsecured, long-tenor, low-interest finance can cover up to 50% of project cost, addressing deep-tech’s “valley of death”. Example: TRL-4+.
2. Crowding-in R&D: India’s GERD is only 0.64% of GDP, with business contributing 41%; the Fund directly tackles weak industry participation. Example: Private R&D.
3. Commercialisation architecture: ANRF’s Special Purpose Fund channels resources through SLFMs such as TDB and BIRAC, combining expertise. Example: Lab-to-market.
4. Strategic technology: Quantum, robotics, space, AI, biotechnology, advanced materials and clean energy strengthen technological sovereignty amid geopolitical restrictions. Example: Semiconductors.
5. Early evidence: By July 2026, TDB had approved 22 projects with ₹2,192 crore RDI support against ₹4,744 crore total project cost; BIRAC shortlisted eight projects worth ₹390.35 crore. Example: Scale-up.
6. Ecosystem and inclusion: NITI Aayog’s Pathways to Progress highlights deep-tech’s capital intensity, specialised skills; it also notes metro concentration. Wider SLFMs can deepen university-industry translation. Example: Innovation clusters.

Governance and Conflict-of-Interest Challenges

1. Structural conflict: It was found that 15 of 22 beneficiaries had investment ties to seven committee members, involving over ₹1,377 crore. This does not prove wrongdoing, but raises concerns.
2. Safeguards versus perception: Disclosure, mandatory recusal, super-majority voting reduce influence; government says conflicted members had zero involvement in evaluation/sanction. Yet indirect network effects remain.
3. Public-money asymmetry: Unlike private venture capital, the State bears downside exposure; corporate-style disclosure may therefore be insufficient for public legitimacy. Example: Fiduciary duty.
4. Selection bias: TRL-4+ eligibility can favour already-funded ventures with networks, sidelining first-time innovators. Example: Network advantage.
5. Accountability gap: SLFM multiplication can dilute responsibility without transparent monitoring. Example: Audit trail.

Way Forward

1. Public conflict register: Disclose indirect, fund and family interests. Example: Disclosure.
2. Independent appraisal: Separate scientific eligibility from commercial valuation through peer panels. Example: Dual appraisal.
3. Rotation and cooling-off: Rotate members and restrict linked investments after tenure. Example: Cooling-off.
4. Independent oversight: Add non-voting observers and independent performance audits. Example: Outcome audit.
5. Outcome metrics: Track TRL progression, patents, domestic value addition, exports, jobs and spillovers. Example: KPI dashboard.
6. Diversified fund management: Add SLFMs and quarterly disbursement reviews, as recommended by the Parliamentary committee. Example: Competition.
7. Risk-sharing: Use milestone-based tranches, clawbacks and first-buyer routes for strategic technologies. Example: Milestone funding.

Conclusion

President Droupadi Murmu’s 2026 Republic Day address celebrated scientists and entrepreneurs advancing self-reliance; RDI must ensure innovation is matched by integrity, inclusion, accountability and public trust for Viksit Bharat 2047.